Hong Kong Stock Movement | GenFleet Therapeutics-B (02595.HK) rose nearly 5% in morning trading; GFH276 has received clinical approval for multiple innovative combination therapies and will conduct research both domestically and internationally.
Zhitong Finance APP has learned that GenFleet Therapeutics-B (02595.HK) rose nearly 5% in early trading. As of press time, it was up 3.84% at HK$19.48, with a turnover of HK$15.6191 million.
Latest
